The FDA Just Spent a Full Day on Testosterone for Menopausal Women
On September 17, 2026 the FDA convened a full-day public workshop on testosterone in menopausal women. What the evidence actually supports, the four gaps holding up approval, and how to put your experience on the federal record before October 19.




















